Skip to main navigation

Skip to content

Search

Toggle search form
- Search for:
Follow us on Twitter
Connect with us on LinkedIn

Investor Relations

Our Team
Our Development Program
For Patients
Investors/Media
Join Us
Contact Us

Search for:

Press Releases

Q3 2022 Infinity Pharmaceuticals, Inc. Earnings Conference Call

Nov 14, 2022 at 8:30 AM EST

Listen to webcast

Keyword Search

Year:

Summary Toggle Infinity to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

November 22, 2021 at 8:35 AM EST
Summary Toggle Infinity Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Company Update

November 2, 2021 at 4:05 PM EDT
Summary Toggle Infinity Announces the Date of Its Third Quarter 2021 Financial Results Conference Call and Webcast

October 26, 2021 at 7:35 AM EDT
Summary Toggle Infinity to Participate in Oppenheimer’s Fall Healthcare Life Sciences and MedTech Summit and the 3rd Annual Macrophage-directed Therapies Summit

September 13, 2021 at 8:35 AM EDT
Summary Toggle Infinity Pharmaceuticals Appoints Robert Ilaria, Jr., M.D., as Chief Medical Officer and Brian Schwartz, M.D., to Its Board of Directors

September 7, 2021 at 7:35 AM EDT
Summary Toggle Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences

September 2, 2021 at 8:35 AM EDT
Summary Toggle Infinity Pharmaceuticals Reports Inducement Grants to Chief Scientific Officer under Nasdaq Listing Rule 5635(c)(4)

August 3, 2021 at 8:00 AM EDT
Summary Toggle Infinity Pharmaceuticals Presents Updated Data from Phase 2 MARIO-275 Trial in Urothelial Cancer (UC) and Phase 2 MARIO-3 Trial in Triple Negative Breast Cancer (TNBC)

July 27, 2021 at 7:31 AM EDT
Summary Toggle Infinity Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Company Update

July 27, 2021 at 7:30 AM EDT
Summary Toggle Infinity Pharmaceuticals Hosting Webinar on MARIO-3 and MARIO-275 Phase 2 Trials

July 20, 2021 at 8:35 AM EDT

Pagination

First page
Previous page
…
Page 3
Current page 4
Page 5
Page 6
…
Next page
Last page

Shareholder Tools

RSS Feeds

RSS Feeds
Email Alerts

Email Alerts
Print

Print
Email

Email

Infinity Pharmaceuticals, Inc.

1100 Massachusetts Ave
Cambridge, MA 02138
617-453-1000

Terms and Conditions

Terms & Conditions
Privacy Policy
Forward Looking Statements

Connect With Us

Our Team

Our Team

Our Development Program

Our Development Program

Investor / Media

Investors/Media

Join Us

Join Us

© 2023 Infinity Pharmaceuticals, Inc. All Rights Reserved.